Use your browser's BACK button to return to your page of origin.
Education, training, and communication for HPV vaccines (Chapter 25).
Vaccine 2006; 24(Suppl 3):S3210-S3218.
Sherris J, Friedman A, Wittet S, Davies P, Steben M, Saraiya M.
Abstract
As human papillomavirus (HPV) vaccines come to market, they will face education
and training challenges similar to those of other new vaccines, along with
HPV-specific issues. Recent studies document stark knowledge gaps about HPV
at all levels - among policy makers, healthcare providers, parents, and teens
- in both the industrialized and developing worlds. Pharmaceutical companies,
public health advocates, medical trainers, and health educators need to understand
their diverse audiences and respond appropriately to the needs of each. They
also must use research-based communication strategies and materials to most
effectively, and accurately, convey the need for an HPV vaccine and to manage
expectations about how the vaccine can, and cannot, protect women and men.